Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02823990
Title TG4010 and Nivolumab in Patients With Lung Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of California, Davis

lung non-small cell carcinoma


MVA-MUC1-IL2 vaccine + Nivolumab

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST